Co-colonization by multidrug-resistant bacteria in two Greek intensive care units

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 10, 2015, Pages 1947-1955

  Papadimitriou Olivgeris, M ^a   Spiliopoulou, I ^a   Christofidou, M ^a   Logothetis, D ^b   Manolopoulou, P ^c   Dodou, V ^c   Fligou, F ^b   Marangos, M ^a   Anastassiou, E D ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; COLISTIN; GLYCOPEPTIDE; LINEZOLID; METRONIDAZOLE; QUINOLONE DERIVATIVE; TIGECYCLINE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIUM ISOLATE; BLA KPC GENE; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FECES ANALYSIS; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; KPC PRODUCING KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MECA GENE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TRACHEOSTOMY; VANA GENE; VANB GENE; VANCOMYCIN RESISTANT ENTEROCOCCUS; AGED; ANTIBIOTIC RESISTANCE; COMPARATIVE STUDY; CROSS INFECTION; DRUG EFFECTS; ENTEROCOCCUS; GREECE; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MIDDLE AGED; PROSPECTIVE STUDY; TIME FACTOR;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; FEMALE; GREECE; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; VANCOMYCIN RESISTANCE;

EID: 84941365319     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2436-4     Document Type: Article

References (25)

1. Kofteridis DP, Valachis A, Dimopoulou D, Maraki S, Christidou A, Mantadakis E, Samonis G (2014) Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case–case–control study. J Infect Chemother 20(5):293–297
2. Glasner C, Albiger B, Buist G, Tambić Andrasević A, Canton R, Carmeli Y, Friedrich AW, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Nordmann P, Poirel L, Rossolini GM, Seifert H, Vatopoulos A, Walsh T, Woodford N, Donker T, Monnet DL, Grundmann H; European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group (2013) Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill 18(28). pii: 20525
3. Drougka E, Foka A, Liakopoulos A, Doudoulakakis A, Jelastopulu E, Chini V, Spiliopoulou A, Levidiotou S, Panagea T, Vogiatzi A, Lebessi E, Petinaki E, Spiliopoulou I (2014) A 12-year survey of methicillin-resistant Staphylococcus aureus infections in Greece: ST80-IV epidemic? Clin Microbiol Infect 20(11):O796–O803
4. European Centre for Disease Prevention and Control (ECDC) (2013) Annual Epidemiological Report 2013. Reporting on 2011 surveillance data and 2012 epidemic intelligence data. ECDC, Stockholm. Available online at: http://ecdc.europa.eu/en/publications/Publications/Annual-Epidemiological-Report-2013.pdf. Accessed 30 March 2015
5. Schwaber MJ, Lev B, Israeli A, Solter E, Smollan G, Rubinovitch B, Shalit I, Carmeli Y; Israel Carbapenem-Resistant Enterobacteriaceae Working Group (2011) Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 52(7):848–855
6. Papadimitriou-Olivgeris M, Drougka E, Fligou F, Kolonitsiou F, Liakopoulos A, Dodou V, Anastassiou ED, Petinaki E, Marangos M, Filos KS, Spiliopoulou I (2014) Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients. Infection 42(6):1013–1022
7. Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Sklavou C, Vamvakopoulou S, Anastassiou ED, Filos KS (2013) KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis 77(2):169–173
8. Kalafati M (2012) How Greek healthcare services are affected by the Euro crisis. Emerg Nurse 20(3):26–27
9. Kaier K, Mutters NT, Frank U (2012) Bed occupancy rates and hospital-acquired infections—should beds be kept empty? Clin Microbiol Infect 18(10):941–945
10. Clinical and Laboratory Standards Institute (CLSI) (2011) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard—Seventh edition. CLSI document M7-A7. CLSI, Wayne, PA
11. Queenan AM, Bush K (2007) Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 20(3):440–458
12. Bell J, Turnidge J, Coombs G, O’Brien F (1998) Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Commun Dis Intell 22(11):249–252
13. Petinaki E, Arvaniti A, Dimitracopoulos G, Spiliopoulou I (2001) Detection of mecA, mecR1 and mecI genes among clinical isolates of methicillin-resistant staphylococci by combined polymerase chain reactions. J Antimicrob Chemother 47(3):297–304
14. Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Bartzavali C, Anastassiou ED, Filos KS (2012) Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother 67(12):2976–2981
15. Yamakawa K, Tasaki O, Fukuyama M, Kitayama J, Matsuda H, Nakamori Y, Fujimi S, Ogura H, Kuwagata Y, Hamasaki T, Shimazu T (2011) Assessment of risk factors related to healthcare-associated methicillin-resistant Staphylococcus aureus infection at patient admission to an intensive care unit in Japan. BMC Infect Dis 11:303
16. Hayakawa K, Marchaim D, Bathina P, Martin ET, Pogue JM, Sunkara B, Kamatam S, Ho K, Willis LB, Ajamoughli M, Patel D, Khan A, Lee KP, Suhrawardy U, Jagadeesh KK, Reddy SM, Levine M, Ahmed F, Omotola AM, Mustapha M, Moshos JA, Rybak MJ, Kaye KS (2013) Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation. Eur J Clin Microbiol Infect Dis 32(6):815–820
17. Furuno JP, Perencevich EN, Johnson JA, Wright MO, McGregor JC, Morris JG Jr, Strauss SM, Roghman MC, Nemoy LL, Standiford HC, Hebden JN, Harris AD (2005) Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization. Emerg Infect Dis 11(10):1539–1544
18. McKinnell JA, Miller LG, Eells SJ, Cui E, Huang SS (2013) A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol 34(10):1077–1086
19. Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC (2008) Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis 46(5):668–674
20. Jung E, Byun S, Lee H, Moon SY, Lee H (2014) Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization. Am J Infect Control 42(10):1062–1066
21. Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G, Michalopoulos A (2007) Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother 60(5):1124–1130
22. Celen MK, Tamam Y, Hosoglu S, Ayaz C, Geyik MF, Apak I (2006) Multiresistant bacterial colonization due to increased nurse workload in a neurology intensive care unit. Neurosciences (Riyadh) 11(4):265–270
23. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D; Sepsis Occurrence in Acutely Ill Patients Investigators (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34(2):344–353
24. Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO (2009) Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 30(12):1180–1185
25. Papadimitriou-Olivgeris M, Giormezis N, Fligou F, Liakopoulos A, Marangos M, Anastassiou ED, Petinaki E, Filos KS, Spiliopoulou I (2013) Factors influencing linezolid-nonsusceptible coagulase-negative staphylococci dissemination among patients in the intensive care unit: a retrospective cohort study. Chemotherapy 59(6):420–426